214 related articles for article (PubMed ID: 25325860)
1. A review of corneal melting after Boston Keratoprosthesis.
Robert MC; Dohlman CH
Semin Ophthalmol; 2014; 29(5-6):349-57. PubMed ID: 25325860
[TBL] [Abstract][Full Text] [Related]
2. Collagen cross-linking of the Boston keratoprosthesis donor carrier to prevent corneal melting in high-risk patients.
Robert MC; Arafat SN; Ciolino JB
Eye Contact Lens; 2014 Nov; 40(6):376-81. PubMed ID: 25320957
[TBL] [Abstract][Full Text] [Related]
3. The Boston keratoprosthesis type II: the Massachusetts Eye and Ear Infirmary experience.
Pujari S; Siddique SS; Dohlman CH; Chodosh J
Cornea; 2011 Dec; 30(12):1298-303. PubMed ID: 21963861
[TBL] [Abstract][Full Text] [Related]
4. Infliximab after Boston Keratoprosthesis in Stevens-Johnson Syndrome: An Update.
Robert MC; Črnej A; Shen LQ; Papaliodis GN; Dana R; Foster CS; Chodosh J; Dohlman CH
Ocul Immunol Inflamm; 2017 Jun; 25(3):413-417. PubMed ID: 27015032
[TBL] [Abstract][Full Text] [Related]
5. Corneal Melt after Boston Keratoprosthesis: Clinical Presentation, Management, Outcomes and Risk Factor Analysis.
Bouhout S; Robert MC; Deli S; Harissi-Dagher M
Ocul Immunol Inflamm; 2018; 26(5):693-699. PubMed ID: 28080168
[TBL] [Abstract][Full Text] [Related]
6. Long-term outcomes of MICOF keratoprosthesis in the end stage of autoimmune dry eyes: an experience in China.
Huang Y; Dong Y; Wang L; Du G; Yu J; Song J; Chiang HH
Br J Ophthalmol; 2012 Jan; 96(1):28-33. PubMed ID: 21454379
[TBL] [Abstract][Full Text] [Related]
7. The Boston keratoprosthesis in the management of corneal limbal stem cell deficiency.
Sejpal K; Yu F; Aldave AJ
Cornea; 2011 Nov; 30(11):1187-94. PubMed ID: 21885964
[TBL] [Abstract][Full Text] [Related]
8. Incidence, Risk Factors, and Surgical Management of Boston Type 1 Keratoprothesis Corneal Melts, Leaks, and Extrusions.
Chan CC; LoVerde L; Qiang J; Nordlund ML; Holland EJ
Cornea; 2016 Aug; 35(8):1049-56. PubMed ID: 27391092
[TBL] [Abstract][Full Text] [Related]
9. The Boston keratoprosthesis in Stevens-Johnson syndrome.
Sayegh RR; Ang LP; Foster CS; Dohlman CH
Am J Ophthalmol; 2008 Mar; 145(3):438-44. PubMed ID: 18207122
[TBL] [Abstract][Full Text] [Related]
10. Boston type 1 based keratoprosthesis (Auro Kpro) and its modification (LVP Kpro) in chronic Stevens Johnson syndrome.
Basu S; Sureka S; Shukla R; Sangwan V
BMJ Case Rep; 2014 Mar; 2014():. PubMed ID: 24663249
[TBL] [Abstract][Full Text] [Related]
11. Clinical features and prognosis of Boston type I keratoprosthesis-associated corneal melt.
Utine CA; Tzu JH; Akpek EK
Ocul Immunol Inflamm; 2011 Dec; 19(6):413-8. PubMed ID: 22106908
[TBL] [Abstract][Full Text] [Related]
12. Russian Keratoprosthesis in Stevens-Johnson Syndrome.
Ma X; Xiang R; Meng X; Qin L; Wu Y; Tain L; Jiang Y; Huang Y; Wang L
Cornea; 2017 Mar; 36(3):304-309. PubMed ID: 27941382
[TBL] [Abstract][Full Text] [Related]
13. Retroprosthetic membrane and risk of sterile keratolysis in patients with type I Boston Keratoprosthesis.
Sivaraman KR; Hou JH; Allemann N; de la Cruz J; Cortina MS
Am J Ophthalmol; 2013 May; 155(5):814-22. PubMed ID: 23352344
[TBL] [Abstract][Full Text] [Related]
14. Keratoprosthesis in dry eye disease.
Sharma S; Donthineni PR; Iyer G; Chodosh J; de la Paz MF; Maskati Q; Srinivasan B; Agarwal S; Basu S; Shanbhag SS
Indian J Ophthalmol; 2023 Apr; 71(4):1154-1166. PubMed ID: 37026247
[TBL] [Abstract][Full Text] [Related]
15. Boston keratoprosthesis type 1 surgery: use of frozen versus fresh corneal donor carriers.
Robert MC; Biernacki K; Harissi-Dagher M
Cornea; 2012 Apr; 31(4):339-45. PubMed ID: 22269678
[TBL] [Abstract][Full Text] [Related]
16. Gamma-irradiated corneas as carriers for the Boston type 1 keratoprosthesis: advantages and outcomes in a surgical mission setting.
Fadlallah A; Atallah M; Cherfan G; Awwad ST; Syed ZA; Melki SA
Cornea; 2014 Mar; 33(3):235-9. PubMed ID: 24457451
[TBL] [Abstract][Full Text] [Related]
17. Vitreoretinal aspects of permanent keratoprosthesis.
Klufas MA; Yannuzzi NA; D'Amico DJ; Kiss S
Surv Ophthalmol; 2015; 60(3):216-28. PubMed ID: 25890625
[TBL] [Abstract][Full Text] [Related]
18. [Mid- and Longterm Experiences with the Boston-Keratoprosthesis. The Cologne and Salzburg Perspective].
Schaub F; Bachmann BO; Seyeddain O; Moussa S; Reitsamer HA; Cursiefen C
Klin Monbl Augenheilkd; 2017 Jun; 234(6):770-775. PubMed ID: 28586930
[No Abstract] [Full Text] [Related]
19. The Boston type I keratoprosthesis: improving outcomes and expanding indications.
Aldave AJ; Kamal KM; Vo RC; Yu F
Ophthalmology; 2009 Apr; 116(4):640-51. PubMed ID: 19243830
[TBL] [Abstract][Full Text] [Related]
20. Longer-term vision outcomes and complications with the Boston type 1 keratoprosthesis at the University of California, Davis.
Greiner MA; Li JY; Mannis MJ
Ophthalmology; 2011 Aug; 118(8):1543-50. PubMed ID: 21397948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
